
Background: The origin of the histological chronic inflammation of the salivary gland in patients with primary Sjogren’s Syndrome (pSS) is questionable. It is probably a consequence of both, the evolution of the disease itself and ageing
Objectives: This study aims to evaluate histological data of chronicity of minor salivary gland biopsy with clinical characteristics and time of evolution in a series of patients with pSS.
Methods: A cross-sectional study including 98 subjects fulfilling the ACR-EULAR 2017 classification criteria for pSS. All patients underwent a minor salivary gland biopsy requested as per clinical practice. We collected the age at diagnosis and at biopsy, xeroftalmia and xerostomia evolution time, and stimulated and unstimulated salivary flow as a clinical data. We informed the following features in the minor salivary gland biopsy: the focus score (positive if ≥ 1), atrophy, fibrosis and adiposity all graded in negative, mild, moderate, and severe stages according to pathological criteria.
Results: This study included 98 patients with pSS. the median of all recruited parameters are shown in
Description of variables included in the study.
| Categories | N(%)Median(IQR) | |
|---|---|---|
| Age at diagnosis(years) | 55.220 (51.097, 58.407) | |
| Age at biopsy (years) | 57.719 (53.851, 61.333) | |
| Xerostomia (months) | 19.614 (10.480, 35.121) | |
| Xeroftalmia (months) | 21.487 (8.148, 38.735) | |
| Focus score (positive) | 63 (64.3%) | |
| USF (ml/15 min) | 2.000 (1.400, 3.000) | |
| SSF (ml/ 5min) | 4.500 (3.000, 5.000) | |
| Atrophy | Negative | 28 (28.7%) |
| Mild | 37 (38.1%) | |
| Moderate | 23 (23.7%) | |
| Severe | 9 (9.3%) | |
| Fibrosis | Negative | 29 (30.5%) |
| Mild | 40 (42.1%) | |
| Moderate | 26 (27.4%) | |
| Adiposity | Negative | 39 (41.1%) |
| Mild | 38 (40%) | |
| Moderate | 18 (18.9%) |
USF: Unstimulated salivary flow, SSF: Stimulated salivary flow
Conclusion: An older age both, at diagnosis and at biopsy are associated with a severe stage of atrophy, fibrosis, and adiposity. Patient with severe atrophy shows less positive focus score, which might be noticed for biopsy interpretation
Disclosure of Interests: None declared